Breaking News

Cellceutix Selects Dr. Reddy’s for Drug Formulation

Dr. Reddy's to provide formulation development services for Brilacidin

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cellceutix Corp. has selected Dr. Reddy’s Custom Pharmaceutical Services (CPS), part of the Pharmaceutical Services and Active Ingredients (PSAI) business unit of Dr. Reddy’s Laboratories Ltd., for the formulation of its defensin mimetic drug Brilacidin for use in ophthalmic and otitis infections.   Research has shown that Brilacidin has a high residence time on the surface of the eye with negligible systemic exposure, suggesting that Brilacidin has the potential to treat ophthalmic ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters